Introduction
============

Allogeneic hematopoietic stem cell transplantation (aHSCT) represents a curative treatment option for patients with hematological malignancies. Today, G-CSF mobilized peripheral blood stem cell (PBSC) products, rather than bone marrow, are the predominant source of stem cells used in transplantation. Both stem cell sources differ in their cellular composition. In particular, PBSC grafts contain approximately 10 times more T cells than those derived from bone marrow ([@b1]). Despite the higher number of T cells transfused along with PBSCs, the incidence of acute graft-versus-host disease (aGvHD) after transplantation is not significantly higher with PBSC grafts compared to bone marrow transplants. This fact has been explained by a Th2 polarization of T cells in the graft induced by G-CSF ([@b2]). However, the influence of G-CSF on the donor T cell repertoire remains unknown.

The success of aHSCT is, however, compromised by two additional factors, namely, relapse of the underlying malignancy and infectious complications. While aGvHD can be eliminated by T cell depletion of the graft, the incidence of relapse and infectious complication increases dramatically due to delayed recovery of the donor T cell compartment. Even if the PBSC graft is not T cell depleted, quantitative and qualitative reconstitution of the T cell compartment in the host requires several months and tends to remain incomplete ([@b3],[@b4]). Delayed T cell reconstitution and restricted T cell receptor (TCR) diversity after transplantation are associated with increased reactivation of latent viruses such as cytomegalovirus (CMV) and Epstein--Barr virus (EBV) ([@b5]--[@b8]). Once full donor chimerism in recipients is achieved and donor hematopoiesis is the only source for T cells, the donor T cell repertoire is solely responsible for controlling latent viruses. Therefore, we hypothesized that the T cell repertoire diversity of the donor after G-CSF mobilization determines later clinical outcome of recipients.

The high diversity of the human T cell repertoire is mainly generated by somatic recombination among the variable (V), diversity (D), and joining (J) TCRβ gene segments and the addition of random nontemplated bases at recombination junctions. The hypervariable complementarity-determining region 3 (CDR3) of the rearranged TCRβ represents the antigen-binding site and can generate more than 10^6^ unique TCRβ receptor rearrangements ([@b9]).

Several strategies have been developed over the last two decades to study the composition and diversity of the T cell repertoire, including flow cytometry and spectratyping ([@b10]--[@b13]). However, none of these attempts has managed to generate individual sequences or frequencies of unique TCRβ rearrangements. This has changed with technical advances in high-throughput sequencing (HTS), which now allow the analysis of T cell repertoires based on sequence analysis of TCRβ rearrangements ([@b14]--[@b16]).

To test our hypothesis that T cell diversity of stem cell donors is important for the clinical course of recipients, we employed an approach that combines multiplex TCRβ PCR employing DNA extracted from flow cytometry--sorted CD4^+^ and CD8^+^ T cells with HTS. To this end, we analyzed peripheral blood samples of 23 donors obtained before G-CSF--induced stem cell mobilization and at the day of stem cell apheresis. By correlation with clinical outcomes of the stem cell recipients, we demonstrated that reduced TCRβ diversity of the CD4^+^ T cell compartment after G-CSF mobilization of the donor is associated with reactivation of CMV and EBV in the recipients.

Materials and Methods
=====================

Samples acquisition and recipient data
--------------------------------------

Peripheral blood samples of six healthy volunteers were used after informed consent to determine the robustness and reliability of our HTS-based TCRβ analysis (Table [1](#tbl1){ref-type="table"}).

###### 

Characteristics of healthy control individuals

  Control individual   Age    No. of clonotypes CD4^+^ cells   No. of clonotypes CD8^+^ cells   
  -------------------- ------ -------------------------------- -------------------------------- ------
  1                           24                               2555                             2566
  2                           29                               2529                             2513
  3                           38                               2464                             1800
  4                           22                               2383                             2547
  5                    A      44                               3002                             1904
  B                    2937   1338                                                              
  6                    A      29                               2830                             1734
  B                    2943   2376                                                              

Number of different clonotypes in the CD4^+^ and CD8^+^ T cell compartments measured by HTS as well as the age of six healthy control individuals. A and B represent two different flow cytometry sorts of the same blood sample.

To study T cell diversity in donors before and after G-CSF induced stem cell mobilization, peripheral blood samples of 23 allogeneic, HLA-matched (10/10) donors were analyzed before G-CSF mobilization and on the day of apheresis. Gender, age, donor type, virus (CMV, EBV) status of stem cell donors and recipient outcomes were assessed (Table [2](#tbl2){ref-type="table"}). Recipients (see also [Table S1](#SD1){ref-type="supplementary-material"}) were transplanted and monitored at the Department of Hematology and Oncology (University of Erlangen) after aHSCT.

###### 

Characteristics of 23 stem cell donors and corresponding recipients

  Donor   Recipient                                                              
  ------- ----------- ---- ----- ------ ------ ------ ------ ------ ------ ----- -----
  1       M           57   SIB   neg.   pos.   2454   2288   887    840    No    Yes
  2       M           30   MUD   neg.   pos.   3034   3110   2350   2369   No    No
  3       M           20   MUD   neg.   pos.   2198   2604   1938   2231   Yes   No
  4       M           33   SIB   neg.   neg.   2786   2825   1984   1254   No    No
  5       F           51   SIB   neg.   pos.   2562   2596   1871   2140   No    No
  6       M           23   MUD   pos.   pos.   2380   1542   1489   1400   Yes   Yes
  7       M           58   SIB   neg.   pos.   2410   3061   NA     NA     No    No
  8       M           50   MUD   pos.   pos.   2617   2674   1503   1295   No    No
  9       M           44   MUD   pos.   pos.   NA     NA     995    1085   Yes   No
  10      F           61   SIB   neg.   pos.   2020   2629   1433   1577   No    No
  11      F           51   SIB   neg.   pos.   2773   2810   2592   1519   No    No
  12      M           45   MUD   pos.   pos.   2655   2552   1903   2027   Yes   Yes
  13      M           30   MUD   neg.   pos.   2575   2687   2296   2427   Yes   Yes
  14      M           51   MUD   neg.   pos.   2403   2143   941    1520   Yes   No
  15      M           48   SIB   neg.   pos.   2493   2065   508    1088   Yes   No
  16      M           20   MUD   pos.   neg.   2373   2084   2054   1729   Yes   No
  17      M           32   MUD   pos.   pos.   2859   2503   1642   1666   Yes   No
  18      M           48   MUD   pos.   pos.   2189   2292   941    1380   Yes   Yes
  19      M           40   MUD   neg.   neg.   2674   2602   2141   1668   No    No
  20      M           41   MUD   neg.   neg.   2054   2795   1764   2381   No    No
  21      M           49   MUD   neg.   pos.   2853   2577   1813   1508   No    No
  22      M           40   SIB   pos.   pos.   2245   1866   2400   2021   No    Yes
  23      M           45   MUD   pos.   pos.   2294   2477   1434   1414   Yes   Yes

Gender, age, donor type, virus (CMV and EBV) status, and number of clonotypes of the CD4^+^ and CD8^+^ T cell compartments of stem cell donors before and after G-CSF mobilization as well as clinical data (CMV and EBV reactivation) of corresponding recipients.

CMV, cytomegalovirus; EBV, Epstein--Barr virus; F, femal; G-CSF, granulocyte colony-stimulating factor; MUD, matched unrelated donor; M, male; NA, not available; SIB, sibling donor.

Virus reactivation was monitored by specific quantitative real-time PCR (for details see Supplementary Methods in Supporting Information). Ethical approval for this study was given by the local ethics review board of the University of Erlangen (Re. No. 4224).

Cell sorting
------------

Whole blood samples were processed by density gradient centrifugation (Ficoll, GE Healthcare, UK) to obtain mononuclear blood cells (PBMCs). For flow cytometric sorting, PBMCs were stained with CD4, CD8, CD14 and TCRαβ antibodies (for details see Supplementary Methods in Supporting Information). Cells were gated on (i) vital lymphocytes in forward/side scatter, (ii) exclusion of doublets and (iii) TCRαβ^+^ CD14^negative^ T cells. CD4^+^ and CD8^+^ T cells were sorted into separate tubes. A purity of \>98.0% was achieved.

DNA isolation
-------------

DNA was extracted from CD4^+^ and CD8^+^ flow cytometry--sorted T cells using Qiagen AllPrep DNA/RNA Mini Kit (Qiagen, Hilden, Germany). Quantification of the extracted DNA was done employing Qubit® 1.0 Fluorometer (Invitrogen, Carlsbad, CA).

Amplification and sequencing of TCRβ gene rearrangements
--------------------------------------------------------

TCRβ gene rearrangements were amplified by a multiplex PCR approach, which includes 58 primers initially described by Robins et al ([@b14]), but was redesigned for our purpose: (i) all primer sequences were re-evaluated and modified in order to allow a more homogeneous amplification of the various TCRβ rearrangements ([Table S3](#SD1){ref-type="supplementary-material"}); (ii) employing a two-step PCR strategy, the TCRβ amplicons were tagged with universal Illumina adapter sequences, including an additional barcode during a second amplification step, allowing parallel sequencing of several samples on Illumina HiSeq2000 (Illumina, San Diego, CA); and (iii) using the Illumina paired-end technology (2 × 100 bp) our amplicon sequences covered the entire CDR3 length and Vβ and Jβ segments in parts providing higher sequence accuracy.

The multiplex primers used contain a universal adapter sequence as a tail at the 5′ end complementary to the 3′ ends of second amplification adaptor primers. The adaptor PCR primers contained universal sequences that permitted solid-phase PCR on the Illumina Genome Analyzer (HiSeq2000 Sequencing System).

Primary amplification (final volume: 50 µL) was processed, including 100 ng DNA, 1.0 µM equimolar Vβ and Jβ primer pools, 1× PCR buffer, 3 mM MgCl~2~, 0.2 mM of each dNTP and 1 U AmpliTaq Gold DNA Polymerase (Applied Biosystems, Foster City, CA). The amplification was performed on a DNA thermal cycler (GeneAmp® PCR System 9700, Applied Biosystems) for 34 cycles at 62°C annealing temperature.

All PCR products were purified using the QIAquick PCR Purification Kit (Qiagen) and diluted (final amount: 500 pg) for further amplifications. Adapter PCRs were set up with 1× Phusion HF Buffer, 1.0 µM forward and reverse adapter primers, 0.05 mM of each dNTP and 1 U Phusion High-Fidelity DNA Polymerase (Finnzymes, Espoo, Finland). Secondary amplification was performed for 12 cycles at 58°C annealing temperature. Products were isolated from a 2% agarose gel using the Wizard® SV Gel and PCR Clean-Up System (Promega, Mannheim, Germany). DNA concentration was determined via the Qubit® 1.0 Fluorometer (Invitrogen).

Generated Illumina libraries were sequenced on a HiSeq2000 analyzer using paired-end modus with 2 × 100 bp read length and joining of read-pairs was performed by an in-house developed algorithm. Paired-end amplicon sequencing resulted in highly accurate sequence reads due to the overlap of related single sequence reads which is of great advantage over single-read-based clustering approaches. After read-pair joining, all identical and related sequence reads that deviated up to 1 bp mismatch were clustered and designated as unique TCRβ clonotypes. Clonotypes below a cut-off of 0.01% of all reads were regarded as background signals and neglected. According to the ImMunoGeneTics information system (<http://www.imgt.org>), the clonotype-specific Vβ and Jβ segments were assigned and the TCRβ CDR3 sequence was translated to *in silico* protein sequence. The TCRβ CDR3 sequence was defined as all amino acids (AAs) starting from the conserved 5′ cysteine in the Vβ segment and ending at the conserved 3′ phenylalanine in the Jβ segment.

Statistical analyses
--------------------

Nonparametric analysis between data groups was performed by the Mann--Whitney *U*-test using GraphPad PRISM 6 software. Linear correlations between T cell diversity and patient age were tested by calculation of the Pearson\'s correlation coefficient. Contingency tables estimating Pearson\'s Chi square were generated using IBM SPSS Statistics software (version 22). A p-value \< 0.05 was considered significant.

The TCRβ repertoire diversity was validated by employing the Shannon entropy for which a maximum entropy of 14 500 clonotypes per sample (equal to the number of T cells in 100 ng DNA) was assumed ([@b17]).

Results
=======

Validation of the TCRβ composition in healthy control individuals
-----------------------------------------------------------------

To demonstrate the reliability and robustness of our approach, we amplified the TCRβ gene rearrangements of flow cytometry--sorted CD4^+^ and CD8^+^ T cells derived from six healthy control volunteers (designated as "controls"; Table [1](#tbl1){ref-type="table"}). For comparability, the same amount of DNA (100 ng DNA extracted from sorted T cells) representing the same number of T cells (approximately 14 500 T cells) was employed in each TCRβ PCR multiplex assay. After Illumina sequencing of the PCR products, a mean of approximately 4 610 000 joined sequence reads were generated per sample. In a first step, reads with identical TCRβ gene rearrangements were clustered leading to a mean of 2705 (range: 2383--3002) rearrangements for the CD4^+^ T cells and 2097 (range: 1338--2566) rearrangements for the CD8^+^ T cells. Clusters of identical TCRβ gene rearrangements were designated as clonotypes. The comparison of these clonotypes with germline Vβ and Jβ segments revealed very similar Vβ and Jβ usage in all samples ([Figure 1](#fig01){ref-type="fig"}A), which is in harmony with published data ([@b18]). Additional proof for the robustness of our data was given by the CDR3 size distribution ([Figure 1](#fig01){ref-type="fig"}B), which revealed a Gaussian-like curve almost identical to size distribution generated by conventional capillary electrophoresis (GeneScan) ([@b19]). Individual CDR3 length distribution graphs are given in [Figure S2](#SD1){ref-type="supplementary-material"}.

![TCRβ analysis in healthy control individuals. (A) Vβ subgroup usage of TCRs from CD4^+^ (left panel) or CD8^+^ (middle panel) T cells of six untreated healthy control individuals (designated as "C1" to "C6"). Seven of the most frequent Vβ subgroups were illustrated individually. The remaining subgroups were compiled. The nomenclature according to the international ImMunoGeneTics information system (IMGT) was used. The right panel shows mean frequencies of all six controls for CD4^+^ and CD8^+^ T cells. (B) HTS-derived CDR3 length distribution of CD4^+^ (left panel) or CD8^+^ (right panel) TCRβ sequences for each control donor. The right panel shows mean frequencies of all donors. TCRβ CDR3 size was defined as all amino acids (AAs) from the conserved cysteine in the Vβ segment to the conserved phenylalanine in the Jβ segment. (C) The left and middle panels show the individual clonotype frequency distribution of CD4^+^ or CD8^+^ T cells of each control donor. The right panel shows the mean values of CD4^+^ and CD8^+^ T cells of all control donors. Each dot represents the occurrence (percentage) of a distinct TCRβ clonotype. Only the clonotype frequencies for the first 250 clonotypes were illustrated. (D) Diversity dot plot of CD4^+^ and CD8^+^ T cells for six healthy control individuals. Each dot shows the number of unique clonotypes detected in one donor. The bars illustrate the mean value of the groups. (E) Overlaps of individual clonotypes in CD4^+^ or CD8^+^ T cells of one control donor sequenced twice out of one T cell preparation (5A) and of two separate cell sorts (5A/B). (F) Overlaps of individual clonotypes in CD4^+^ or CD8^+^ T cells of distinct control individuals.](ajt0015-2170-f1){#fig01}

Although the Vβ and Jβ usage was highly similar in the two different T cell populations, the frequency and number of clonotypes (designated as diversity) in CD4^+^ and CD8^+^ T cells in our control samples revealed a statistically significant difference. In the CD4^+^ T cell fractions, the most frequent clonotype comprised 0.8% of all sequence reads (mean), whereas in the CD8^+^ T cell compartments the mean of the most common clonotype was 4.7% of all reads ([Figure 1](#fig01){ref-type="fig"}C). In consequence, a higher number of different clonotypes could be demonstrated in the CD4^+^ T cell fraction ([Figure 1](#fig01){ref-type="fig"}D). Taken together, CD4^+^ T cells showed a significantly higher diversity in their TCRβ repertoire compared to the CD8^+^ T cell compartment.

In order to determine the re-occurrence of identical clonotypes within individual control donors, we analyzed aliquots of the same DNA preparations of the same CD4^+^ and CD8^+^ sorted T cells in duplicate. In addition, we employed DNA preparations derived from different flow cytometry sorts of the same peripheral blood sample. The analysis of two different aliquots of the same DNA preparation revealed an overlap of 4.1% identical clonotypes for CD4^+^ T cells and an overlap of 13.7% for CD8^+^ T cells ([Figure 1](#fig01){ref-type="fig"}E). Comparing the different flow cytometry sorts of the same peripheral blood sample, the overlap was marginally lower leading to 3.2% identical clonotypes in CD4^+^ T cells and 9.2% in CD8^+^ T cells, respectively. Strikingly, the overlap of clonotypes between two different individuals in our study was less than 0.2% in CD4^+^ and CD8^+^ T cells ([Figure 1](#fig01){ref-type="fig"}D). Whereas the extremely rare coincidence of identical TCRβ rearrangements in different individuals is expected, the low overlap within the same DNA preparation or same T cell sort of the same individual implies that the T cells analyzed are composed to a large extent of unique TCRβ rearrangements. This is in line with the results of Warren et al ([@b16]), who demonstrated a similar low overlap between the TCRβ repertoires of different whole peripheral blood samples from one individual.

Analysis of TCRβ repertoire in stem cell donors before and after G-CSF mobilization
-----------------------------------------------------------------------------------

To monitor changes in the TCRβ repertoire during stem cell mobilization, we investigated the presence and frequency of TCRβ gene rearrangements in CD4^+^ and CD8^+^ T cells of 23 stem cell donors before G-CSF administration (pre) and on the days of stem cell apheresis (post) consisting of 88 samples in total (Table [2](#tbl2){ref-type="table"}).

Analysis of the Vβ segment usage showed neither in CD4^+^ nor in CD8^+^ T cells a significant modification after G-CSF administration ([Figure 2](#fig02){ref-type="fig"}A) and the CDR3 length distribution remained unaffected ([Figure S3](#SD1){ref-type="supplementary-material"}).

![TCR analysis in stem cell donors before and after G-CSF induced mobilization. (A) Mean Vβ subgroup usage of TCRs from CD4^+^ or CD8^+^ T cells of 23 donors before (pre) and after (post) G-CSF induced stem cell mobilization. The seven most frequent Vβ subgroups were illustrated individually; the remaining subgroups were grouped together. The nomenclature according to the international ImMunoGeneTics information system (IMGT) was used. (B) Mean percentage of overlaps of individual clonotypes in CD4^+^ or CD8^+^ T cells of the 23 donors pre-- and post--G-CSF--induced stem cell mobilization. (C and D) Diversity dot plots of CD4^+^ and CD8^+^ T cells pre-- and post--G-CSF mobilization. Each dot represents the number of unique clonotypes detected in individual donors. (C) The number of clonotypes in CD4^+^ T cells differs significantly before and after G-CSF mobilization from the number of clonotypes in the CD8^+^ compartment (\*\*\*\*p \< 0.0001; n = 44). Bars show mean values. (D) The number of clonotypes in CD4^+^ and CD8^+^ T cells is not affected by G-CSF administration. (E) Scatter plots of CD4^+^ and CD8^+^ clonotype numbers and the age for stem cell donors pre-- and post--G-CSF mobilization. The number of individual CD8^+^ clonotypes decreases with increasing donor age irrespective of G-CSF mobilization (preMOB: r = −0.42; p = 0.052; postMOB: r = −0.42; p = 0.051; n = 22). For CD4^+^ T cells, no negative correlation was found. CD4^+^ T cells preMOB; CD4^+^ T cells postMOB; CD8^+^ T cells preMOB; CD8^+^ T cells postMOB.](ajt0015-2170-f2){#fig02}

The pairwise comparison of individual T cell repertoires before and after G-CSF mobilization in the 23 donors revealed a mean overlap of 1.6% for CD4^+^ and 6.2% for CD8^+^ T cells ([Figure 2](#fig02){ref-type="fig"}B), which is in harmony with the results of our six control individuals. The lower percentage is most likely explained by the fact that the samples of the controls were taken at the same time, whereas the samples of the stem cell donors were drawn at different time points before and after G-CSF mobilization. Regarding the number of different TCRβ clonotypes in CD4^+^ and CD8^+^ T cells, we found a significantly higher diversity of TCRβ gene rearrangements in CD4^+^ T cells compared to CD8^+^ T cells ([Figure 2](#fig02){ref-type="fig"}C; q \< 0.0001; n = 44). However, the overall diversity of CD4^+^ and CD8^+^ T cells remained unaffected during G-CSF mobilization ([Figure 2](#fig02){ref-type="fig"}D) and was independent of the increased number of T cells in the peripheral blood after G-CSF administration (Figures [S4](#SD1){ref-type="supplementary-material"} and [S5](#SD1){ref-type="supplementary-material"}).

Interestingly, in CD8^+^ T cells the TCRβ diversity correlated negatively with increasing donor age independent of mobilization state ([Figure 2](#fig02){ref-type="fig"}E; preMOB: r = −0.42; p = 0.052; postMOB: r = −0.42; p = 0.051; n = 22). Thus, our data confirm the notion that the TCRβ repertoire in CD8^+^ T cells is decreasing as a function of age ([@b20]).

Impact of the donor\'s viral status on TCR diversity during G-CSF induced mobilization
--------------------------------------------------------------------------------------

Since a preceding infection with herpes viruses (Table [2](#tbl2){ref-type="table"}) may impact TCRβ diversity, we analyzed the repertoire of CMV-seropositive and CMV-seronegative donors separately ([Figure 3](#fig03){ref-type="fig"}A). As a result, we could demonstrate a significantly higher number of clonotypes in the CD4^+^ T cell compartment after G-CSF mobilization of CMV-seronegative donors compared to CMV-seropositive donors (p = 0.0158). On average, G-CSF *per se* does not influence the TCR repertoire in both T cell subsets irrespective of the virus status of the donors ([Figure S6](#SD1){ref-type="supplementary-material"}).

![Donor TCRβ diversity and clinical correlation. (A) Diversity dot plots of CD4^+^ and CD8^+^ T cells of cytomegalovirus (CMV)-seropositive or -seronegative donors before (pre) and after (post) G-CSF mobilization. Only for the CD4^+^ T cell compartment postmobilization a significant difference could be displayed between CMV-seropositive and -seronegative donors (\*p \< 0.05; neg. n = 14; pos. n = 8). (B) Diversity dot plots of CD4^+^ and CD8^+^ TCRβ rearrangements of G-CSF--mobilized donors premobilization and postmobilization according to patients either reactivated ("Yes") or not ("No") with CMV ("Yes": CD4^+^ n = 10; CD8^+^ n = 11) or Epstein--Barr virus (EBV; "Yes": CD4^+^ n = 7; CD8^+^ n = 7). Cases with CMV and/or EBV reactivation presented significantly lower numbers of unique clonotypes in CD4^+^ T cells post--G-CSF mobilization (\*p \< 0.05). In CD8^+^ T cells, no significant difference could be detected for virus reactivation. (C) Diversity dot plots of CD4^+^ and CD8^+^ T cells of donor T cells premobilization and postmobilization according to patients who either exhibited acute graft-versus-host disease (aGvHD; "Yes") or not ("No"). No significant correlation could be detected between donor T cell diversity and aGvHD appearance in patients. CD4^+^ T cells preMOB; CD4^+^ T cells postMOB; CD8^+^ T cells preMOB; CD8^+^ T cells postMOB.](ajt0015-2170-f3){#fig03}

However, four donors were EBV-seronegative. Interestingly, three of these donors were double negative for CMV and EBV and therefore presented higher numbers of clonotypes in their CD4^+^ T cells as shown above. In line, the only EBV-seronegative but CMV-seropositive donor displayed a reduced number of clonotypes in the CD4^+^ T cell compartment after G-CSF administration.

Correlation of clinical outcomes after stem cell transplantation with TCRβ diversity of the stem cell donors
------------------------------------------------------------------------------------------------------------

Next we correlated the CD4^+^ and CD8^+^ T cell repertoires before and after G-CSF mobilization with various clinical outcomes of the patients after aHSCT. Remarkably, a reduced diversity of the TCRβ repertoire of the donors CD4^+^ T cell compartment after G-CSF mobilization was significantly correlated with EBV and CMV reactivation ([Figure 3](#fig03){ref-type="fig"}B; CMV: p = 0.0137; EBV: p = 0.0377). Employing the cumulative incidence of viral reactivation revealed that significantly more patients receiving grafts with lower TCRβ diversity reactivated CMV and EBV, although the serostatus of patients and donors for both viruses was different ([Figure S1](#SD1){ref-type="supplementary-material"}). In contrast, the diversity of the CD8^+^ T cell compartment has no impact on the viral reactivation irrespective of G-CSF mobilization. In addition, we could not identify a correlation between the development of aGvHD and the transferred TCRβ repertoire diversity at any mobilization stage ([Figure 3](#fig03){ref-type="fig"}C). These observations remained stable despite the inclusion of the donor age in our analyses (data not shown). Furthermore, neither the correlation of the Vβ segment usage of donor T cells nor the reactivation of CMV and/or EBV showed any association with the development of aGvHD in the corresponding recipients ([Figure S7](#SD1){ref-type="supplementary-material"}; [Table S2](#SD1){ref-type="supplementary-material"}).

In order to verify our observations, we generated contingency tables using the donor TCRβ diversity in the CD4^+^ and CD8^+^ T cell compartment after G-CSF mobilization and various clinical outcomes of the stem cell recipients. The T cell diversity was categorized into high and low based on its deviation from the mean value. According to this classification, the correlation between lower donor CD4^+^ TCRβ diversity and virus reactivation (CMV and EBV) was again significant (Table [3](#tbl3){ref-type="table"}; CMV: χ^2^-test, p = 0.035; EBV: χ^2^-test, p = 0.020). In addition, a significant difference between lower CD8^+^ TCRβ diversity and the age of the donor (χ^2^-test, p = 0.035) could be demonstrated. Thus, our observation of a negative correlation between donor CD4^+^ T cell repertoire diversity and virus reactivation in stem cell--transplanted patients as well as a restricted CD8^+^ TCRβ repertoire in elderly donors was confirmed via contingency tables (Table [3](#tbl3){ref-type="table"}).

###### 

TCRβ repertoire diversity and clinical correlation

                             CD4^+^ T cells   CD8^+^ T cells                                 
  ------------------ ------- ---------------- ---------------- ------- --- ---- ---- ------- --
  Donor type         MUD     9                5                14          8    7    15      
  SIB                5       3                8                0.933   2   5    7    0.277   
  Donor age          \<40    5                2                7           5    2    7       
  \>40               8       5                13               0.658   3   10   14   0.035   
  *Patient*                                                                                  
  Survival           Alive   9                7                16          8    9    17      
  Dead               5       1                6                0.240   2   3    5    0.781   
  TRM                Alive   11               7                18          9    10   19      
  Dead               3       1                4                0.601   1   2    3    0.650   
  Relapse            No      10               6                16          6    10   16      
  Yes                4       2                6                0.856   4   2    6    0.221   
  EBV reactivation   No      12               3                15          7    8    15      
  Yes                2       5                7                0.020   3   4    7    0.867   
  CMV reactivation   No      10               2                12          5    6    11      
  Yes                4       6                10               0.035   5   6    11   1.000   
  aGvHD              No      4                2                6           2    4    6       
  Yes                10      6                16               0.856   8   8    16   0.484   

Contingency table of donor CD4^+^ and CD8^+^ T cell diversity post--G-CSF mobilization in correlation with clinical parameters of the recipients. Groups were divided according to their clonotype numbers above or below the compartment mean (CD4^+^ mean = 2490 clonotypes; CD8^+^ mean = 1661 clonotypes). According to this classification, a correlation between lower donor CD4^+^ TCRβ diversity and virus reactivation (CMV and EBV) was significant. In addition, a significant correlation could be demonstrated between lower CD8^+^ TCRβ diversity and the age of the donor.

aGvHD, acute graft-versus-host disease; χ^2^-test, chi-squared test; TRM, transplant-related mortality.

Finally, to independently validate the diversity of the TCRβ repertoires, we employed the Shannon entropy for each sample. Thereby, it could be confirmed that a higher CD4^+^ T cell repertoire in donors after G-CSF--induced stem cell mobilization is associated with a lower virus reactivation in the related recipients ([Figure S8](#SD1){ref-type="supplementary-material"}A; Mann--Whitney *U*-test: CMV: p = 0.034; EBV: p = 0.003) and that the CD8^+^ TCRβ repertoire is restricted in elderly donors ([Figure S8](#SD1){ref-type="supplementary-material"}B; Pearson\'s correlation: preMOB: r = −0.55; p = 0.008; postMOB: r = −0.52; p = 0.013; n = 22).

Discussion
==========

After aHSCT, delayed reconstitution of the donor T cell compartment with respect to cell number but also T cell repertoire is regarded as a risk factor for relapse and infectious complications ([@b3],[@b5],[@b7],[@b21]). So far, previous studies focused on the impact of T cell development in the recipients after aHSCT not considering the T cell repertoire of the donors. However, the donor-derived repertoire---especially after G-CSF mobilization---lays the basis for T cell composition in the stem cell recipient and therefore may have great impact for the clinical course after transplantation. Hence, we analyzed the T cell composition of the stem cell donors before G-CSF mobilization and on the day of apheresis. Thanks to the advances in HTS techniques, we were able to assess the TCR beta (TCRβ) repertoire diversity of the donors and correlated the results with the clinical outcome of the corresponding stem cell recipients.

For a more adequate interpretation of the data generated from the stem cell donors, we additionally analyzed flow cytometry--sorted CD4^+^ and CD8^+^ T cells isolated from a control cohort of six healthy volunteers. Consistent with published findings, we demonstrated a very similar usage of the Vβ and Jβ gene segments and a Gaussian-like distribution of the CDR3 length in all six individuals ([Figure 1](#fig01){ref-type="fig"}A and B) ([@b18]). Furthermore, our analysis led to the identification of more dominant clonotypes in CD8^+^ T cells in comparison to CD4^+^ T cells ([Figure 1](#fig01){ref-type="fig"}C) ([@b22]). In consequence, the analyzed CD4^+^ T cell compartment displayed a higher T cell diversity ([Figure 1](#fig01){ref-type="fig"}D). This observation is also in perfect harmony with published data and confirms the reliability of our approach ([@b23]). Of special interest are the results derived from the comparison of the T cell composition of (i) different DNA aliquots from the same DNA preparation of the same T cell sort, (ii) different T cell sorts of the same individual at the same time point and (iii) sorted T cells of different individuals. Merely 4.1% and 3.2% of the TCRβ rearrangements were found to be identical after bioinformatics analysis of the HTS data when the two DNA aliquots of the same CD4^+^ T cell sort or the different CD4^+^ T cell sorts of the same individual, respectively, were compared. Consistent with the lower diversity of the CD8^+^ T cell compartment, the percentage of overlapping TCRβ rearrangements was higher in the two DNA aliquots and in both CD8^+^ T cell sorts of the same individual (13.7% and 9.2%; [Figure 1](#fig01){ref-type="fig"}E). In contrast, there was almost no overlap in the TCR repertoires of the CD4^+^ or CD8^+^ T cell compartment of different individuals (0.03% and 0.19%; [Figure 1](#fig01){ref-type="fig"}F). Much higher overlaps might be anticipated in repeated analysis of samples derived from same individuals. However, the low percentage of identical T cell rearrangements in the same DNA preparation or in identical cell sorts is very logical in light of the enormous T cell heterogeneity in healthy individuals ([@b9]). This implies that the DNA aliquots (100 ng equivalent to approx. 14 500 T cells) subjected to multiplex TCRβ PCR and HTS largely consist of individual TCRβ rearrangements not present in the second DNA aliquot or parallel T cell sorts. Only those rearrangements that occur at higher frequencies will be identified in two independent PCRs. This is precisely the reason as to why in CD8^+^ T cells the overlap is higher in the two DNA aliquots or in the same T cell sort of the same individual as compared to the CD4^+^ T cells. We are well aware of the fact that we analyzed only a very small fraction of the entire T cell repertoire of a given individual, but we are very much convinced that our HTS approach is representative enough to reliably reflect T cell composition and T cell diversity.

Our TCR analysis approach was then applied to monitor the T cell diversity of the CD4^+^ and CD8^+^ T cells of 23 allogeneic stem cell donors before G-CSF administration and on the day of apheresis. These analyses confirmed the higher diversity in the CD4^+^ T cell compartment, which was in line with our control experiments and indicated no significant changes in the Vβ and Jβ usage, the CDR3 length distribution and the diversity of the CD4^+^ and CD8^+^ T cell compartment under G-CSF administration ([Figures 2](#fig02){ref-type="fig"}A and D and [S2](#SD1){ref-type="supplementary-material"}). Furthermore, we neither observed a correlation of diversity with the increase of T cell numbers after G-CSF mobilization in the peripheral blood nor with T cell numbers in the graft as a large randomly drawn sample of the peripheral blood ([Figure S5](#SD1){ref-type="supplementary-material"}), indicating that G-CSF indiscriminately mobilizes T cells into the peripheral blood. Moreover, we were able to illustrate that the TCRβ repertoire in CD8^+^ T cells is reduced as a function of age ([Figure 2](#fig02){ref-type="fig"}E; Table [3](#tbl3){ref-type="table"}). This observation is supported on a molecular level by previous data showing that CD8^+^ T cells lose their naïve T cell compartment more rapidly than CD4^+^ T cells during mid-adulthood and most recently published data confirmed age-related decreases in TCRβ repertoire diversity by HTS ([@b24],[@b25]).

The idea of our study is based on the assumption that the T cell composition of the donor after G-CSF mobilization is of crucial importance for the clinical outcome of the stem cell recipient. To this end, we compared the TCRβ rearrangements of the CD4^+^ and CD8^+^ T cells of 23 donors after stem cell mobilization with various clinical outcomes of the recipients. Those comparisons revealed no statistically significant correlations with one striking exception: We found that a lower CD4^+^ T cell diversity in donors after G-CSF mobilization was associated with reactivation of CMV and EBV in the stem cell recipients ([Figure 3](#fig03){ref-type="fig"}B; Table [3](#tbl3){ref-type="table"}). These results complement very nicely a previously described association of CMV or EBV infection with lower TCR diversity, which was only analyzed in recipients and not in donors ([@b23]). However, it remains unclear to which extent the observed association between lower CD4^+^ T cell diversity and EBV reactivation could be a side effect of CMV reactivation.

Our data clearly demonstrate that HTS of the amplicons generated by TCRβ multiplex PCR provides a tool of crucial importance to study T cell repertoire and T cell diversity at the level of individual TCRβ gene rearrangements. This is also valid for small sample sizes with limited numbers of T cells. Thus, our approach is also applicable in clinical situations where merely specimens with low T cell counts are available.

In summary, the concept that the T cell repertoire before stem cell transplantation impacts the clinical outcome of recipients after aHSCT could be confirmed by our data. Reduced T cell diversity in the CD4^+^ T cell compartment of the donors after G-CSF mobilization and, in consequence, limited T cell diversity in the patient after transplantation is associated with viral reactivation. This notion supports concepts that would allow for rapid and early increase of the donor T cell repertoire by adoptive T cell therapy ([@b26]--[@b28]). Finally, since reduced TCRβ repertoires in donors correlate with an increased likelihood of viral reactivation in stem cell recipients, our TCRβ approach might pave the way for risk assessment of virus reactivation in patients.
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aGvHD

:   acute graft-versus-host disease

aHSCT

:   allogeneic hematopoietic stem cell transplantation

CDR3

:   hypervariable complementarity-determining region 3

CMV

:   cytomegalovirus

EBV

:   Epstein--Barr virus

G-CSF

:   granulocyte colony-stimulating factor

HTS

:   high-throughput sequencing

TCRβ

:   T cell receptor beta
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Supplementary Methods

**Figure S1: Cumulative incidence of viral reactivation after allogeneic stem cell transplantation.** Reactivation was monitored weekly by PCR method. Number of clonotypes in donors after G-CSF mobilization was grouped in below and above mean value.

**Figure S2: CDR3 length distribution in healthy control individuals.** HTS-derived CDR3 length distribution of (A) CD4^+^ or (B) CD8^+^ TCRβ sequences for every control donor (C1--C6).

**Figure S3: HTS-derived CDR3 length distribution of TCRβ sequences in G-CSF mobilized stem cell donors.** HTS-derived CDR3 length distribution of CD4^+^ TCRβ sequences before (pre, A) or after (post, B) G-CSF--induced stem cell mobilization as well as the HTS-derived CDR3 length distribution of CD8^+^ TCRβ sequences pre--(C) or post--(D) G-CSF administration for every stem cell donor.

**Figure S4: Cell counts in peripheral blood of donors before and after G-CSF administration.** Diversity dot blots of cell counts of peripheral blood lymphocyte subsets before stem cell mobilization (preMOB) via G-CSF and at the day of apheresis (postMOB). Leukocytes were gated as CD45^+^ and lymphocytes as CD45^high^CD14^−^ cells. Within the lymphocytic population, T cells were determined as CD3^+^, B cells as CD19^+^, NK cells as CD56^+^ CD3^−^ cell populations. T cell subpopulations were analyzed upon CD4 and CD8 expression. Cell counts per µL whole blood were calculated based on the number of beads and the sample volume in TruCount tubes (BD Biosciences, Franklin Lakes, NJ). The numbers of all lymphocytic subsets increased significantly after G-CSF administration (Mann--Whitney *U*-test).

**Figure S5: TCR diversity in correlation with cell numbers of the donor peripheral blood or the stem cell graft.** Scatter plots of CD4^+^ and CD8^+^ T cell diversity and (A) absolute T cell counts (CD4^+^ and CD8^+^ T cells) in peripheral blood of stem cell donors post--G-CSF mobilization and (B) cell counts of CD3^+^ cells (per kg recipient bodyweight) in the graft. There was no correlation of TCRβ diversity with peripheral blood cell counts.

**Figure S6: CD4**^**+**^ **TCR repertoire diversity of CMV/EBV-seropositive or -seronegative donors before and after G-CSF mobilization.** Diversity dot blots of CMV- and/or EBV-seronegative (left panel) and -seropositive donors (right panel). Changes in CD4^+^ T cell diversity after G-CSF treatment are independent of the serostatus of the donor.

**Figure S7: Vβ subgroup usage in donors whose recipients later suffered from GvHD.** Mean frequencies of Vβ subgroup usage of TCRs from CD4^+^ (A) or CD8^+^ (B) T cells in donors segregated by appearance of aGvHD in recipients. Seven of the most frequent Vβ subgroups were illustrated individually in the bar plot (left panel). The remaining subgroups were compiled. The nomenclature according to the international ImMunoGeneTics information system (IMGT) was used. The right panel shows the individual frequencies of all donors. No significant differences could be shown between these two groups.

**Figure S8: Donor TCRβ analyses using Shannon entropy (H**~**S**~**).** (A) Diversity dot plots of CD4^+^ and CD8^+^ T cell preparation from G-CSF mobilization grouped according to reactivation of CMV or EBV. Donors of patients without CMV and/or EBV reactivation showed significant higher diversity in the CD4^+^ T cell compartment post--G-CSF mobilization (\*p = 0.034; \*\*p = 0.003). In CD8^+^ T cells, no significant difference could be detected. (B) Scatter plots of CD8^+^ T cell diversity and the age for stem cell donors pre-- and post--G-CSF mobilization. The diversity of CD8^+^ T cells decreases with increasing donor age irrespective of G-CSF mobilization (preMOB: r = −0.55; p = 0.008; postMOB: r = −0.52; p = 0.013; n = 22).

**Table S1:** Characteristics of 23 stem cell recipients.

**Table S2:** Risk factors for aGvHD incidence.

**Table S3:** Primer sequences.

[^1]: These authors contributed equally to this work.
